Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis

BACKGROUND: Several trials have demonstrated protective effects from inhibition of sodium‐glucose cotransporter 2 among patients with type 2 diabetes mellitus. There is uncertainty about the consistency of the cardiovascular benefits achieved across patient subsets. METHODS AND RESULTS: We included...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnott, Clare, Li, Qiang, Kang, Amy, Neuen, Brendon L., Bompoint, Severine, Lam, Carolyn S. P., Rodgers, Anthony, Mahaffey, Kenneth W., Cannon, Christopher P., Perkovic, Vlado, Jardine, Meg J., Neal, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033896/
https://www.ncbi.nlm.nih.gov/pubmed/31992158
http://dx.doi.org/10.1161/JAHA.119.014908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033896/
https://www.ncbi.nlm.nih.gov/pubmed/31992158
http://dx.doi.org/10.1161/JAHA.119.014908

Ejemplares similares